Related Experiment Video
Updated: Aug 5, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Intestinal Microbiome, Fecal Fermentation Profile, and Health Indices in HIV-Positive Men Versus Normal Controls
Mary C Andreae1,2, William A Clark1,2, John Sterrett3
1College of Health Sciences, East Tennessee State University, Johnson City, TN 37614, USA.
Highly active antiretroviral therapy (HAART) in HIV+ males is linked to altered gut bacteria and short-chain fatty acids (SCFAs), impacting lipid metabolism and liver health. These microbiome changes may contribute to metabolic complications in HIV+ men who have sex with men (MSM).
Area of Science:
- Microbiome research
- Metabolic disorders
- HIV/AIDS research
Background:
- Highly active antiretroviral therapy (HAART) is associated with metabolic complications in HIV-positive (HIV+) individuals, including non-alcoholic fatty liver disease (NAFLD) and lipodystrophy.
- Intestinal dysbiosis, often characterized by a Prevotella-rich enterotype, is frequently observed in HIV+ males on HAART.
- Gut microbial fermentation produces short-chain fatty acids (SCFAs) crucial for host metabolism, but their role in HIV-associated metabolic complications is not fully understood.
Purpose of the Study:
- To investigate the relationships among HAART, anthropometrics, diet, intestinal permeability, gut microbiota composition, and lipodystrophy in HIV+ males.
- To characterize the gut microbiome and SCFA profiles in HIV+ males compared to HIV-negative controls.
- To explore potential links between gut dysbiosis, SCFA production, and metabolic disturbances in HIV+ males.
Main Methods:
- A cohort of 40 males (19 HIV+ and 20 HIV- controls) was enrolled.
- Stool samples were analyzed for 16S rRNA gene sequencing and SCFA quantification (gas chromatography).
- Anthropometric measures (BMI, H:W ratio), liver health (FibroScan), and serum markers of intestinal permeability were assessed.
Main Results:
- HIV+ males showed significantly higher hip-to-waist ratios and hepatic steatosis compared to controls.
- Elevated concentrations of isobutyrate, isovalerate, and valerate were found in HIV+ participants, while butyrate and total APB were higher in HIV- males.
- HIV+ participants exhibited greater abundances of Prevotella and Lachnospiraceae in their gut microbiota.
Conclusions:
- HIV+ males on HAART present distinct gut microbiome profiles and altered SCFA production.
- These findings suggest disrupted lipid metabolism and highlight potential microbiome-metabolism interactions in HIV+ males.
- The study provides a basis for further research into the role of the gut microbiome in metabolic complications among HIV+ men who have sex with men (MSM).
Related Concept Videos
Development of Human Microbiota
Dysbiosis of the Gut Microbiota
Microbiota of the Urogenital Tract
Serum Laboratory Studies, Stool Test, Breath Test
What is Monogastric Digestion?
Introduction to the Human Microbiota

